{"id":202607,"name":"KITE PHARMA, INC.","slug":"kite-pharma-inc","state":"CA","country":"United States of America","description":"","totalSpending":460000,"filings":5,"yearlySpending":[{"year":2018,"income":380000},{"year":2019,"income":80000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["KITE PHARMA, INC."],"lobbyists":["ANNA GRIFFIN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to CAR T; policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program.","Issues related to CAR T; policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program.","Issues related to CAR T; policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program.","Issues related to CAR T; policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program.","Issues related to CAR T; policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program."]}